Italy – A recent study claimed that people who take aspirin daily may be less likely to develop colon cancer.
The research team in Italy analyzed tissue samples from 238 colon cancer patients who were diagnosed with the disease between 2015 and 2019.
It was found that 12% (or 29 people) were long-term users of aspirin.
The study revealed that people who took aspirin daily had higher levels of CD80, a protein associated with high immune cell activity.
It was also found that they had fewer cancer cells around the lymph nodes (small bean-shaped structures that form part of the body’s immune system) and a greater number of immune cells circulating within the tumors.
The researchers explained that the common painkiller “charges” immune cells in the digestive system, which helps repel the multiplication and spread of cancer cells.
“These observations indicate an immune-boosting effect of aspirin in the colon,” they said.
Other studies have linked aspirin use to a reduced risk of colon cancer by up to 40%.
But researchers do not recommend using the drug, which does not require a prescription, as a preventive method, because it can lead to stomach ulcers, internal bleeding and even strokes.
Dr. Mona Rezapour, a gastroenterologist at the University of California, said in response to previous research: “We know that aspirin reduces the risk of colon cancer. “But we don’t recommend it to the general public yet, because the benefits do not outweigh the risks for everyone.”
Source: Daily Mail
#Study #aspirin #daily #reduces #risk #colon #cancer
2024-04-24 13:12:34
